| A fad too far? Dietary strategies for the prevention and treatment of NAFLD MP Moore, RP Cunningham, RJ Dashek, JM Mucinski, RS Rector Obesity 28 (10), 1843-1852, 2020 | 99 | 2020 |
| Relationships between Very Low‐Density Lipoproteins–Ceramides,− Diacylglycerols, and–Triacylglycerols in Insulin‐Resistant Men JM Mucinski, C Manrique‐Acevedo, T Kasumov, TJ Garrett, A Gaballah, ... Lipids 55 (4), 387-393, 2020 | 20 | 2020 |
| High-throughput LC-MS method to investigate postprandial lipemia: considerations for future precision nutrition research JM Mucinski, JE Vena, MA Ramos-Roman, ME Lassman, ... American Journal of Physiology-Endocrinology and Metabolism 320 (4), E702-E715, 2021 | 7 | 2021 |
| The Tailgate Study: differing metabolic effects of a bout of excessive eating and drinking MM Syed-Abdul, M Jacome-Sosa, Q Hu, AH Gaballah, NC Winn, NT Lee, ... Alcohol 90, 45-55, 2021 | 6 | 2021 |
| Understanding the variation in exercise responses to guide personalized physical activity prescriptions J Noone, JM Mucinski, JP DeLany, LM Sparks, BH Goodpaster Cell Metabolism 36 (4), 702-724, 2024 | 5 | 2024 |
| Impact of nicotinamide riboside supplementation on skeletal muscle mitochondria and whole‐body glucose homeostasis: challenging the current hypothesis MP Moore, JM Mucinski The Journal of Physiology 598 (16), 3327-3328, 2020 | 3 | 2020 |
| Relationship between hepatic and mitochondrial ceramides: a novel in vivo method to track ceramide synthesis JM Mucinski, JM McCaffrey, RS Rector, T Kasumov, EJ Parks Journal of Lipid Research 64 (5), 2023 | 1 | 2023 |
| Inverse relationship between very low‐density lipoprotein (VLDL) ceramides, diacylglycerols, and triacylglycerols in human hepatic lipid accumulation JM Mucinski, MM Syed‐Abdul, TJ Garrett, EJ Parks The FASEB Journal 33 (S1), lb567-lb567, 2019 | 1 | 2019 |
| Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH JM Mucinski, AF Salvador, MP Moore, TM Fordham, JM Anderson, ... Journal of Hepatology, 2024 | | 2024 |
| 314-OR: A Randomized Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Mellitus (T1DM) A BILAL, A CASU, F YI, JM MUCINSKI, G MERCOUFFER, DE KELLEY, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| Associations of Skeletal Muscle Mass, Muscle Fat Infiltration, Mitochondrial Energetics, and Cardiorespiratory Fitness with Liver Fat Among Older Adults D Igudesman, J Mucinski, S Harrison, PM Cawthon, J Linge, ... The Journals of Gerontology, Series A: Biological Sciences and Medical …, 2024 | | 2024 |
| Effects of Weight Loss on Testosterone, Abdominal Adiposity and Insulin Sensitivity in Men and Women J Mucinski, D Kelley, B Goodpaster OBESITY 31, 49-49, 2023 | | 2023 |
| Relationships Between Liver Disease, Ceramides (CERs), and Lipogenesis J Mccaffrey, J Mucinski, E Parks OBESITY 31, 258-258, 2023 | | 2023 |
| Labeled breath tests in patients with NASH: Octanoate oxidation relates best to measures of glucose metabolism JM Mucinski, AM Perry, TM Fordham, A Diaz-Arias, JA Ibdah, RS Rector, ... Frontiers in Physiology 14, 1172675, 2023 | | 2023 |
| Lifestyle Treatment in the Regression of NASH: Insulin Resistance, Lipid Synthesis, and Methodological Innovation JM Mucinski University of Missouri-Columbia, 2022 | | 2022 |
| 285-OR: Lifestyle Treatment-Induced Improvements in Nonalcoholic Steatohepatitis (NASH) JM Mucinski, NS Nallapeta, MP Moore, JA Ibdah, RS Rector, EJ Parks Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 310-OR: Role of Glucose Flux to Elevate Hepatic Lipogenesis in Biopsy-Proven NASH JM Mucinski, N Sharma, MP Moore, JA Ibdah, RS Rector, EJ Parks Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 1900-P: Very Low-Density Lipoprotein Ceramides and Hepatic Lipid Accumulation JM Mucinski Diabetes 68 (Supplement_1), 2019 | | 2019 |
